Physician profile
Ashley Grimshaw
NPI 1073994968
$518.68
in general payments reported to CMS, 2019-2025
13 companies · $139 in 2025
The $139 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $154 · 2020: $12.72 · 2021: $20.62 · 2022: $41.70 · 2023: $132 · 2024: $18.69 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $289.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $150.93 | 2019-2025 | Otezla, Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $56.36 | 2019 | |
| Novo Nordisk INC | $54.39 | 2020-2025 | Wegovy, Rybelsus, Ozempic |
| Lilly USA, LLC | $52.05 | 2019-2025 | Mounjaro, Zepbound |
| Astellas Pharma US INC | $35.91 | 2019-2025 | Veozah |
| Glaxosmithkline, LLC. | $30.67 | 2019-2023 | Arexvy |
| Merck Sharp & Dohme LLC | $26.37 | 2019-2023 | Verquvo, Belsomra, Steglatro |
| Dexcom, INC. | $25.75 | 2025 | Dexcom G6 Transmitter |
| Biogen, INC. | $20.62 | 2021 | |
| Abbott Laboratories | $19.14 | 2023 | Freestyle Libre 2 |
| Exact Sciences Corporation | $16.89 | 2023 | Cologuard Collection Kit |
| Grifols USA, LLC | $16.56 | 2019 | |
| Novartis Pharmaceuticals Corporation | $13.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Grimshaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.